Evidence map›Paper›PMID 23975681›Full record

ArticleHuman molecular genetics2014

A model for the molecular underpinnings of tooth defects in Axenfeld-Rieger syndrome.

Xiao Li, Shankar R Venugopalan, Huojun Cao, Flavia O Pinho, Michael L Paine, Malcolm L Snead, Elena V Semina, Brad A Amendt

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Transcriptional Regulation of Dental Epithelial Cell Fate.International journal of molecular sciences · 2020
    Review
  5. Development (Cambridge, England) · 2020
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. A Novel Mutation inMolecular syndromology · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. MSX2 in ameloblast cell fate and activity.Frontiers in physiology · 2014
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xiao LiDepartment of Anatomy and Cell Biology and Craniofacial Anomalies Research Center, The University of Iowa, Iowa City, IA 52244, USA.
Shankar R Venugopalan
Huojun Cao
Flavia O Pinho
Michael L Paine
Malcolm L Snead
Elena V Semina
Brad A Amendt
University of Iowa · USUniversity of Southern California · USMedical College of Wisconsin · US

Funding

Nanotechnology Strategies for Growth of Bones and TeethR01DE015920 · NIDCR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SNEAD, MALCOLM L., STUPP, SAMUEL I · 2005 to 2015
$5.8M
Molecular Mechanisms of Axenfeld-Rieger SyndromeR01EY015518 · NEI · MEDICAL COLLEGE OF WISCONSIN · PI Elena V Semina · 2005 to 2026
$5.6M
Molecular Mechanisms of PITX2 During Craniofacial DevelopmentR01DE013941 · NIDCR · UNIVERSITY OF TULSA · PI AMENDT, BRAD A · 2000 to 2013
$4.2M
Mechanisms of FoxJ1 Tooth MorphogenesisR01DE018885 · NIDCR · UNIVERSITY OF IOWA · PI AMENDT, BRAD A · 2009 to 2012
$1.5M
NEI NIH HHS R01 EY015518NIDCR NIH HHS DE13941NIDCR NIH HHS DE18885NIDCR NIH HHS R01 DE015920
6 · The paper itself

Abstract

Patients with Axenfeld-Rieger Syndrome (ARS) present various dental abnormalities, including hypodontia, and enamel hypoplasia. ARS is genetically associated with mutations in the PITX2 gene, which encodes one of the earliest transcription factors to initiate tooth development. Thus, Pitx2 has long been considered as an upstream regulator of the transcriptional hierarchy in early tooth development. However, because Pitx2 is also a major regulator of later stages of tooth development, especially during amelogenesis, it is unclear how mutant forms cause ARS dental anomalies. In this report, we outline the transcriptional mechanism that is defective in ARS. We demonstrate that during normal tooth development Pitx2 activates Amelogenin (Amel) expression, whose product is required for enamel formation, and that this regulation is perturbed by missense PITX2 mutations found in ARS patients. We further show that Pitx2-mediated Amel activation is controlled by chromatin-associated factor Hmgn2, and that Hmgn2 prevents Pitx2 from efficiently binding to and activating the Amel promoter. Consistent with a physiological significance to this interaction, we show that K14-Hmgn2 transgenic mice display a severe loss of Amel expression on the labial side of the lower incisors, as well as enamel hypoplasia-consistent with the human ARS phenotype. Collectively, these findings define transcriptional mechanisms involved in normal tooth development and shed light on the molecular underpinnings of the enamel defect observed in ARS patients who carry PITX2 mutations. Moreover, our findings validate the etiology of the enamel defect in a novel mouse model of ARS.

Indexed as

AmelogeninAnimalsAnterior Eye SegmentCell LineDental EnamelDisease Models, AnimalEmbryo, MammalianEye AbnormalitiesEye Diseases, HereditaryGene Expression RegulationHMGN2 ProteinHomeobox Protein PITX2Homeodomain ProteinsHumansIncisorMiceAmelogeninHMGN2 ProteinHomeobox Protein PITX2Homeodomain ProteinsTranscription Factors

Identifiers

PMID23975681
PMCPMC3857954
OpenAlexW2142504763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.